ArticleThe Milbank quarterly2007
Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.
Article in The Milbank quarterly, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Off-Label Prescription of Benzodiazepines: A Retrospective Cohort Study of Prescribing Prevalence in Primary Care.Clinical drug investigation · 2025Article
- Emergency contraception subsidy in Canada: a comparative policy analysis.BMC health services research · 2022Article
- Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare.Journal of pharmaceutical policy and practice · 2018Review
- Comparison of Canadian public medication insurance plans and the impact on out-of-pocket costs.CMAJ open · 2017Article
- Evaluating the effects of Quebec's private-public drug insurance system.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2017Review
- Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study.British journal of clinical pharmacology · 2017Article
- Medication access via hospital admission.Canadian family physician Medecin de famille canadien · 2017Article
- Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.BMJ (Clinical research ed.) · 2017Article
- Do stimulant medications improve educational and behavioral outcomes for children with ADHD?Journal of health economics · 2014Article
- Product listing agreements (PLAs): a new tool for reaching Quebec's pharmaceutical policy objectives?Healthcare policy = Politiques de sante · 2013Article
- Factors influencing the quality of local management of ductal carcinoma in situ: a cohort study.Current oncology (Toronto, Ont.) · 2013Article
- Canadian pharmacare: looking back, looking forward.Healthcare policy = Politiques de sante · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In January 1997, the government of Quebec, Canada, implemented a public/private prescription drug program that covered the entire population of the province. Under this program, the public sector collaborates with private insurers to protect all Quebecers from the high cost of drugs. This article outlines the principal features and history of the Quebec plan and draws parallels between the factors that led to its emergence and those that led to the passage of the Medicare Prescription Drug, Improvement and Modernization Act (MMA) in the United States. It also discusses the challenges and similarities of both programs and analyzes Quebec's ten years of experience to identify adjustments that may help U.S. policymakers optimize the MMA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.